CMG Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.020x

CMG Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, CMG Pharmaceutical Co. Ltd (058820) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.08 Billion ≈ $-2.77 Million USD) by net assets (₩201.55 Billion ≈ $136.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CMG Pharmaceutical Co. Ltd (2014–2025)

Cash flow conversion efficiency of CMG Pharmaceutical Co. Ltd from 2014 to 2025. This chart illustrates how CMG Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CMG Pharmaceutical Co. Ltd stock price for real-time trading data and today's change.

CMG Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained

CMG Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CMG Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CMG Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see 058820 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Guangdong Provincial Expressway Development Co Ltd SHE:200429	0.041x
Inventronics Hangzhou Inc SHE:300582	0.014x
WA1 Resources Ltd AU:WA1	0.004x
Shenzhen Huakong Seg Co Ltd SHE:000068	0.070x
Nanjing Zhongbei Group Co Ltd SHE:000421	0.037x
Genesco Inc NYSE:GCO	0.314x
BRBI BR Partners S.A. ADSs NASDAQ:BRBI	0.136x
Jiangsu Hengshang Energy Conservation Technology Co. Ltd. A SHG:603137	N/A

Annual Cash Flow Conversion Efficiency for CMG Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of CMG Pharmaceutical Co. Ltd from 2014 to 2025. Review 058820 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩201.55 Billion ≈ $136.59 Million	₩-11.02 Billion ≈ $-7.47 Million	-0.055x	-3672.48%
2024-12-31	₩189.54 Billion ≈ $128.45 Million	₩290.09 Million ≈ $196.59K	0.002x	-92.55%
2023-12-31	₩190.23 Billion ≈ $128.92 Million	₩3.91 Billion ≈ $2.65 Million	0.021x	-23.03%
2022-12-31	₩184.95 Billion ≈ $125.34 Million	₩4.94 Billion ≈ $3.35 Million	0.027x	-12.40%
2021-12-31	₩184.70 Billion ≈ $125.17 Million	₩5.63 Billion ≈ $3.81 Million	0.030x	+87.47%
2020-12-31	₩181.13 Billion ≈ $122.75 Million	₩2.94 Billion ≈ $2.00 Million	0.016x	+3.72%
2019-12-31	₩180.16 Billion ≈ $122.09 Million	₩2.82 Billion ≈ $1.91 Million	0.016x	+83.76%
2018-12-31	₩103.98 Billion ≈ $70.47 Million	₩886.78 Million ≈ $600.96K	0.009x	-57.12%
2017-12-31	₩97.94 Billion ≈ $66.38 Million	₩1.95 Billion ≈ $1.32 Million	0.020x	-12.90%
2016-12-31	₩101.11 Billion ≈ $68.52 Million	₩2.31 Billion ≈ $1.56 Million	0.023x	-55.67%
2015-12-31	₩46.81 Billion ≈ $31.72 Million	₩2.41 Billion ≈ $1.63 Million	0.052x	+248.22%
2014-12-31	₩49.00 Billion ≈ $33.21 Million	₩724.89 Million ≈ $491.25K	0.015x	--

About CMG Pharmaceutical Co. Ltd

KQ:058820 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$417.79 Million

₩616.50 Billion KRW

Market Cap Rank

#12871 Global

#371 in Korea

Share Price

₩4170.00

Change (1 day)

+0.00%

52-Week Range

₩536.00 - ₩4980.00

All Time High

₩8318.64